Biotest

Clinical trials sponsored by Biotest, explained in plain language.

Biotest BIO0 HAMBURG

A German biopharmaceutical company that develops plasma-derived and biotechnological therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1

Could a plasma protein cut deaths in severe pneumonia?

Disease control Recruiting now

This phase 3 trial tests whether adding trimodulin (a protein mixture from donated blood) to standard care can lower death rates in adults with severe community-acquired pneumonia who need a breathing machine. About 590 hospitalized patients will receive either trimodulin or a pl…

Phase 3 • Sponsor: Biotest • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

Biotest

Could a plasma protein cut deaths in severe pneumonia?